Click on the links to view the statements of use which include full information about the contouring and planning approaches that we are currently testing.
Note, the RPA will not be available for clinical use until it receives its medical device clearance from the US Food and Drug Administration.
Additional information on the algorithms and evaluation can be found in the Publications section of this website.
We are constantly working to increase the available anatomies and treatment planning techniques. Please check back here for updates, or follow our Twitter feed:
@LaurenceECourt